Inhaled nitroglycerin for COPD flare-ups
Part of Lungs & breathing clinical trials.
This trial tests if breathing in a medicine called nitroglycerin can help people with severe COPD and high blood pressure in their lungs. It aims to see if this treatment improves breathing during a COPD exacerbation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are having a serious COPD flare-up that requires help breathing.
- An ultrasound of your heart shows you have high blood pressure in your lungs (pulmonary hypertension).
- You cannot have severe heart failure on the left side of your heart.
- You cannot be pregnant.
- You cannot have an allergy to nitroglycerin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the risk of heart problems in people hospitalized for a sudden worsening of COPD. It aims to understand how COPD flare-ups affect the heart.
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This study tests whether high-flow nasal oxygen (a gentle breathing support through the nose) can help people with a severe COPD flare-up. If you have high carbon dioxide and slightly acidic blood, this treatment might improve your breathing and avoid the need for a breathing tube.
This study looks at how a measurement of inflammation in the breath (called fractional exhaled nitric oxide) relates to COPD flare-ups in people who are already using a triple inhaler therapy. It aims to find better ways to predict and manage COPD exacerbations.
This early trial tests whether inhaled nitric oxide changes how well your lungs exchange gases during exercise in people with COPD, and compares results with healthy volunteers. It may help researchers understand lung blood-flow and breathing differences that could affect symptoms and exercise tolerance.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.